As high expression of CD47 in tumor cells was previously described as a negative prognostic factor in multiple types of cancer, such as breast cancer and ovarian cancer, we first attempted to analyze whether the expression of CD47 varies among histological subtypes of SGC. This evidence concerns the gene CD47 and breast carcinoma.